Up-and-Coming Diagnostic Test Developers Emerge as Consolidation Thins the Field.
10 privately-held diagnostics developers primarily focused on liquid biopsy tests, ranked by total money raised from venture capital firms.
These ten governments have committed funding for projects that will sequence a minimum of 100,000 citizens to spur genomic medicine
If companion diagnostics (CDx) were people, they would be old enough to drink. The first CDx won FDA approval in 1998, when Dako Denmark...
Company expects to deliver 50,000 tests per day of the rapid, instrument-based, isothermal system designed for qualitative detection of infectious diseases.
This year’s list of innovative companies have all found, or developed, technology solutions that have allowed them to become innovators in their niche.
The nation’s largest private health insurer, UnitedHealthcare, announced August 1 that it will cover testing that will allow physicians to match their patients to...
The researchers from Chongqing Medical University in Chongqing, China, also found that people’s antibody response to SARS-CoV-2 may diminish rapidly after infection, which may have implications for the interpretation of negative serological results.
Researchers from four NIH institutes and centers plan to collect and analyze blood samples from up to 10,000 volunteers, with the aim of providing critical data for epidemiological models.
GenapSys’ sequencing system is about the size of an iPad, costs under $10,000, and is based on a proprietary direct electronic sequencing chip, which is intended to eliminate the need for cumbersome equipment.